Article
Genomic landscape and homologous recombination deficiency in malignant germ cell tumors reveals sex-specific therapeutic opportunities.
The Journal of pathology - 1 Jun 2026
Xu Boheng, Chen Jiahong, Peng Huiting, Su Xuan, He Caiyun
Abstract excerpt
Malignant germ cell tumors (GCTs) are relatively rare tumors with limited therapeutic options. This study examined the homologous recombination deficiency (HRD) status and genomic characteristics in 14 patients with GCT who underwent next-generation sequencing. HRD was evaluated using the genomic instability score (GIS), which incorporates three components: loss of heterozygosity (LOH), telomeric allelic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
